Fingerprint
Dive into the research topics of 'NeoPalAna: Neoadjuvant palbociclib, a cyclin-dependent kinase 4/6 inhibitor, and anastrozole for clinical stage 2 or 3 estrogen receptor–positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically